Arrowstreet Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.9M Buy
+2,391,784
New +$23.1M 0.02% 686
2021
Q1
Sell
-25,779
Closed -$1.39M 2429
2020
Q4
$1.39M Sell
25,779
-415,053
-94% -$18.8M ﹤0.01% 1723
2020
Q3
$16.3M Sell
440,832
-162,515
-27% -$6.04M 0.03% 634
2020
Q2
$18.7M Buy
603,347
+344,000
+133% +$9.53M 0.03% 526
2020
Q1
$7.16M Buy
+259,347
New +$7.77M 0.02% 593
2019
Q3
Sell
-106,395
Closed -$2.33M 1661
2019
Q2
$2.33M Buy
+106,395
New +$2.33M 0.01% 867
2019
Q1
Sell
-293,890
Closed -$3.71M 1856
2018
Q4
$3.71M Buy
293,890
+99,525
+51% +$1.48M 0.01% 649
2018
Q3
$2.98M Buy
194,365
+124,822
+179% +$1.73M 0.01% 620
2018
Q2
$912K Buy
+69,543
New +$765K ﹤0.01% 820
2017
Q2
Sell
-170,674
Closed -$1.34M 1244
2017
Q1
$1.34M Buy
+170,674
New +$1.39M ﹤0.01% 903
2016
Q4
Sell
-280,347
Closed -$2.3M 2244
2016
Q3
$2.3M Buy
+280,347
New +$2.35M 0.01% 878

Other funds holding NEO

Arrowstreet Capital's NEO Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in NeoGenomics (NEO) in Q2 2026: 2,391,784 shares worth $34.9M. The stake represents 0.02% of the portfolio and ranks #686 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in NEO as recently as Q4 2020.

Arrowstreet Capital first reported a position in NEO in Q3 2016 and has held it in 11 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Arrowstreet Capital held 2,391,784 shares of NeoGenomics worth $34.9M as of Q2 2026.
  • NeoGenomics was a new Arrowstreet Capital position in Q2 2026.
  • NeoGenomics made up 0.02% of Arrowstreet Capital's portfolio in Q2 2026, its #686 holding.
  • Arrowstreet Capital first reported a position in NeoGenomics in Q3 2016 and has held it in 11 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.